Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
NTIC reported a 12.6% increase in consolidated net sales to $24.2 million for Q3 fiscal 2026, driven by strong demand for ZERUST® and Natur-Tec® products.
IN8bio's Phase 1 trial of DeltEx™ DRI in glioblastoma patients showed median progression-free survival (mPFS) of 16.1 months, more than double the ~6.9-month standard of care benchmark.
Foremost Clean Energy completes Phase 2 of its option agreement with Denison, earning a 51% interest in 10 Athabasca uranium projects (35.78% at Hatchet Lake) 15 months ahead of schedule.
